Clinical Trials Directory

Trials / Completed

CompletedNCT01184573

Novel Breath Test to Detect Early Stage Chronic Pancreatitis

Phase 1 Study of the Pancreatic Breath Test to Detect Early Stage Chronic Pancreatitis Utilizing the Secretin Stimulation Test

Status
Completed
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Metabolic Solutions Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to evaluate the feasibility of using a non-invasive, non-radioactive Pancreatic Breath Test (PBT) as a diagnostic tool to detect early stages of chronic pancreatitis (CP). If successful, this method could have important advantages over existing diagnostic tests for detecting early stage CP. This diagnostic breath test may have a clinical impact if it leads to early detection of CP and intervention to mitigate disease progression.

Detailed description

Disorders of the pancreas affect more than one million persons in this country with nearly $3 billion in health care costs. The incidence rate of chronic pancreatitis (CP) is rapidly increasing and may be related to expanded alcohol abuse. Advanced CP can be easily detected by imaging techniques. However, mild to moderate CP presents a more difficult challenge for clinicians. Imaging techniques fail to recognize less advanced CP cases about 40% of the time. The gold standard for monitoring early stage CP is the secretin stimulation test. However, the secretin stimulation test is only done in a few US centers. The investigators have developed the Pancreatic Breath Test (PBT) as an alternative to the secretin stimulation test. The breath test uses a tracer dose of sodium 13C-bicarbonate to detect the amount of bicarbonate released after stimulation of the pancreatitis by a meal (liquid Ensure). A normal pancreas releases unlabeled bicarbonate upon stimulation, decreasing the ratio of 13C/12C of exhaled carbon dioxide. This ratio will change much less in a diseased pancreas. A case-control study in 25 mild to moderate CP patients and 25 healthy controls will be utilized to show feasibility of the new breath test.

Conditions

Timeline

Start date
2011-05-01
Primary completion
2012-07-01
Completion
2012-09-01
First posted
2010-08-19
Last updated
2014-02-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01184573. Inclusion in this directory is not an endorsement.

Novel Breath Test to Detect Early Stage Chronic Pancreatitis (NCT01184573) · Clinical Trials Directory